Using AI scribes in New Zealand primary care consultations: an exploratory survey.

Abstract

Introduction: AI scribes have had a rapid uptake in primary care across New Zealand (NZ). The benefits of this new technology must be weighed against the potential risks they may pose.

Aim: This study provides a snapshot of AI scribes use in primary care to generate clinical notes. We aimed to understand emerging provider experiences, identify perceived clinical benefits and concerns, and flag potential ethical and legal issues as a basis for future research and policy development.

Methods: GPs and health providers working in primary care across NZ were invited to participate in an anonymous survey about their experience with AI scribes (February-March 2024).

Results: One hundred and ninety-seven respondents completed the survey, 88% (n = 164) of whom were GPs. Of these, 40% (n = 70) had experience with AI scribes. Reported benefits included: reduced multitasking (n = 46), saved time (n = 43), and improved rapport with patients (n = 43). Key concerns included: compliance with NZ legal and ethical frameworks (n = 108), data security (n = 98), errors or omissions (n = 93), and data leaving New Zealand (n = 91). Only 66% (n = 41) had read the terms and conditionss of the AI scribe tool, and 59% (n = 35) reported seeking patient consent. Most (80%, n = 50) found AI scribes helpful or very helpful, and 56% (n = 35) said the tool changed consultation dynamics.

Discussion: While there is strong uptake and enthusiasm for AI scribes in primary care in NZ, critical issues remain around legal and ethical oversight, patient consent, data security, and the broader impact on clinician-patient interactions. Health providers need clearer guidance and regulatory support for safe, ethical, and legal use of AI tools.